Live Breaking News & Updates on Narcotics Division Of The Security Bureau

Stay updated with breaking news from Narcotics division of the security bureau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study

Author summary Why was this study done? There have been an increasing number of cases of type 1 diabetes reported following Coronavirus Disease 2019 (COVID-19) vaccinations. The relationship between receiving COVID-19 vaccines and incident diabetes has not been examined in population-based studies. Several nationwide cohorts reported higher risks of incident diabetes following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. The risk of incident diabetes following infection by SARS-CoV-2 Omicron variants may differ from that following infection by earlier variants. It is also uncertain how vaccination status may influence the risk. What did the researchers do and find? This study included 167,337 CoronaVac, 158,378 BNT162b2 recipients, and 145,199 COVID-19 patients with their respective 1:1 matched control. There was no evidence of increased risks of incident diabetes following COVID-19 vaccination. Regardless of predominant circulating variants, SARS-CoV-2 ....

Hong Kong , United States , University Of Hong Kong , Hong Kong General , United Kingdom , Biontech Fosun Pharma , Amitabh Bipin Suthar , Bristol Myers Squibb , Research Council , Health Bureau Of The Government , Research Fund Secretariat Of The Food , American Statistical Association , Hospital Authority , Hong Kong Hospital Authority , Boehringer Ingelheim , Health Bureau Of The Hong Kong Government , European Commission , Hong Kong Government Vaccination Programme , Narcotics Division Of The Security Bureau , Technology Commission , Sinovac Biotech Hong Kong , National Health , International Classification Of Primary Care , British National Formulary , National Institute For Health Research , Laboratory Of Data Discovery For Health ,